Intestinal-type adenocarcinoma of the Bartholin gland: A case report and literature review.
Adenocarcinoma
Bartholin gland
Immunohistochemistry
Intestinal type
KRAS mutation
Journal
Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
25
03
2021
revised:
06
07
2021
accepted:
13
07
2021
entrez:
12
8
2021
pubmed:
13
8
2021
medline:
13
8
2021
Statut:
epublish
Résumé
To report a case of intestinal-type adenocarcinoma of the Bartholin gland treated successfully with surgery and to review the current literature. We report the case of a 45-year-old white woman with intestinal-type adenocarcinoma of the Bartholin gland treated with wide local excision followed by bilateral inguinal femoral lymph node dissection without adjuvant therapy. We also review the literature on the treatment and management of this rare tumor. We searched Pubmed / MEDLINE databases for previous case reports or series using the keywords "Bartholin gland", "adenocarcinoma" and "intestinal type". We found 19 cases of intestinal-type adenocarcinoma of the Bartholin gland published up to November 2020. The treatments described varied from case to case. Intestinal-type adenocarcinoma of the Bartholin gland has been treated and managed in the same way as squamous carcinoma. Treatment of these cancers is understudied and involves local resection with curative intent. More case reports are needed to determine the best treatment strategies.
Identifiants
pubmed: 34381862
doi: 10.1016/j.gore.2021.100836
pii: S2352-5789(21)00140-5
pmc: PMC8334373
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100836Informations de copyright
© 2021 The Authors. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Eur J Gynaecol Oncol. 2017;38(2):296-302
pubmed: 29953800
Gynecol Oncol. 1995 Apr;57(1):117-20
pubmed: 7535721
J Formos Med Assoc. 2003 Jan;102(1):49-51
pubmed: 12684613
Hum Pathol. 2004 Mar;35(3):377-9
pubmed: 15017596
Gynecol Oncol Rep. 2019 Mar 29;28:133-135
pubmed: 31061870
Gynecol Oncol. 2001 Nov;83(2):409-11
pubmed: 11606106
Crit Rev Oncol Hematol. 2017 Sep;117:1-11
pubmed: 28807231
Obstet Gynecol. 1978 Jan;51(1 Suppl):30s-33s
pubmed: 618471
Mol Clin Oncol. 2016 Apr;4(4):545-548
pubmed: 27073659
Case Rep Pathol. 2017;2017:1765460
pubmed: 28503335
Obstet Gynecol. 1984 Feb;63(2):155-62
pubmed: 6694808
Turk Patoloji Derg. 2018;34(3):255-258
pubmed: 28272666
Obstet Gynecol Sci. 2017 Jul;60(4):369-373
pubmed: 28791269
Gynecol Oncol. 1999 Aug;74(2):298-301
pubmed: 10419750
South Med J. 2001 Jul;94(7):744-6
pubmed: 11531187
Eur J Gynaecol Oncol. 2012;33(4):433-5
pubmed: 23091907
Eur J Gynaecol Oncol. 2016 Aug;37(4):554-557
pubmed: 29894084
J Reprod Med. 1993 Feb;38(2):113-6
pubmed: 8445601
Jpn J Clin Oncol. 2001 May;31(5):226-30
pubmed: 11450999